Official announcements
Safety warnings
|
messages in brief
|
06/03/2017
Due to current events (see screenshot), the Federal Office for Safety in Health Care points out that according to §59 of the Medicines Act, private individuals are prohibited from offering medicines privately for sale to other persons or from trading…
Recall
|
Veterinary Medicines
|
01/03/2017
The marketing authorization holder has informed its supplied customers by letter dated 01.03.2017 that above mentioned batches of "Vetofol 10 mg/ml Emulsion for Injection for Dogs and Cats" are recalled. In individual bottles, parts may come off the…
Recall
|
Medicines
|
23/02/2017
The marketing authorization holder has informed its supplied customers in a letter dated 22.2.2017 that a possible contamination with another active ingredient has been discovered at the manufacturer. For this reason, a recall of the above-mentioned…
messages in brief
|
21/02/2017
Since toxic pyrrolizidine alkaloids (PAs) were detected in high concentrations in herbal medicinal products produced from plants that do not biosynthesize PAs themselves, in March 2016 BASG published risk-minimizing measures that were to be…
Safety warnings
|
messages in brief
|
30/01/2017
New recommendations for levonorgestrel emergency contraceptives in case of interactions with CYP3A4-inducing drugs. In Austria, the current recommendations of the European Medicines Agency are being implemented following a technical review of…
messages in brief
|
23/01/2017
Information on user registration and submission of sales and delivery notifications as well as ways to contact us can be found here . Please note the deadline for submission by the end of March 2017.
Recall
|
Medicines
|
19/12/2016
The marketing authorization holder informed its supplied customers in a letter dated December 15, 2016, that the vials may have cracks in the glass. Therefore, the affected batch is being recalled as a precautionary measure. The company is not aware…
Recall
|
Medicines
|
16/12/2016
In a letter dated December 13, 2016, the marketing authorization holder informed its customers that the above-mentioned batches of "Sertraline Sandoz" and "Lamotrigine Sandoz" are being recalled. During the routine incoming goods inspection on the…
Safety warnings
|
messages in brief
|
14/12/2016
Stem cell and other cell therapies are associated with great hopes, both among physicians and patients. Great progress is expected, especially in the treatment of difficult-to-treat and chronic diseases. For this very reason, however, it is…
Recall
|
Veterinary Medicines
|
06/12/2016
The marketing authorization holder has informed its supplied customers in a letter dated November 30, 2016, that stability tests have revealed a reduced rabies antigen content after 15 months of storage. Therefore, the above mentioned batch of this…